Stocks in Aggressive Mood: AEGON N.V. (NYSE:AEG), DHX MEDIA LTD(NASDAQ:DHXM), TherapeuticsMD, Inc. (NYSEMKT:TXMD)

AEGON N.V. (NYSE:AEG) reported htat its subsidiary, Aegon USA LLC, has reached an contract with Greenspoint Capital and The Newport Group to sell Clark Consulting, its Bank-Owned Life Insurance distribution and servicing unit in the US, for $177.5 million. The Group said the transaction demonstrates its ongoing efforts to further reduce the capital deployed to its run-off businesses and increase the return on capital invested. Aegon noted that the BOLI/COLI insurance block is not part of the deal and will continue to be serviced by the Group’s US subsidiaries. AEGON N.V. (NYSE:AEG) stock hit highest price at $7.57, beginning with a price of $7.55 and reported an increase of 4.28% to close at $7.55 with a day range of $7.51-$7.57.

DHX MEDIA LTD(NASDAQ:DHXM) reported that it will not be proceeding by means of public offering of variable voting shares and common voting shares previously released on July 6, 2015. The termination results from an assessment by DHX’s management that current market conditions are not conducive for an offering on terms that would be in the best interests of DHX’s shareholders. As a result of this termination, no shares will be sold pursuant to the offering.

TherapeuticsMD, Inc. (NYSEMKT:TXMD) released that pricing of an underwritten public offering of around 3.8M shares of its common stock, proposed at a price of $7.80 a share. The gross proceeds to TherapeuticsMD from this proposing are anticipated to be around $30M, before deducting underwriting discounts, commissions and other offering expenses payable by TherapeuticsMD. TherapeuticsMD intends to use a majority of the proceeds of the offering to partially fund validation and qualification of a secondary manufacturing source for its TX-001HR and TX-004HR drug candidates, as well as continued validation and scale-up of the manufacturing processes for these drug candidates, and for other research, clinical formulation and development and general corporate purposes. TherapeuticsMD, Inc. (NYSEMKT:TXMD) stock has highest price of $8.15 in last session, beginning with a price of $8.04 and reported an increase of 1.14% to close at $7.96 with a day range of $7.67-$8.15. The stock is going forward its 52-week low with 131.40% and moving down from its 52 week high price with -7.44%.